Hiroshi Yasuda

Kawasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Changes in cosmic radiation doses of aircraft crew over the COVID-19 pandemic (2019-2022).

Changes in cosmic radiation doses of aircraft crew over the COVID-19 pandemic (2019-2022).

Journal: Frontiers in public health

Published: July 28, 2025

Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study.

Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study.

Journal: Journal of pharmaceutical health care and sciences

Published: May 03, 2025

Recent trends in cosmic radiation exposure onboard aircraft: effects of the COVID-19 pandemic on Japanese in-flight doses.

Recent trends in cosmic radiation exposure onboard aircraft: effects of the COVID-19 pandemic on Japanese in-flight doses.

Journal: Frontiers in public health

Published: January 01, 2025

Effectiveness of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis and 5-aminosalicylate intolerance.

Effectiveness of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis and 5-aminosalicylate intolerance.

Journal: Medicine

Published: October 27, 2024

Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study.

Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study.

Journal: Journal of gastroenterology and hepatology

Published: September 19, 2024

The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective study.

The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective study.

Journal: Intestinal research

Published: August 09, 2024

Trends and Changes in Endoscopic Management and Clinical Outcomes of Colonic Diverticular Bleeding during the Coronavirus Disease-2019 Pandemic.

Trends and Changes in Endoscopic Management and Clinical Outcomes of Colonic Diverticular Bleeding during the Coronavirus Disease-2019 Pandemic.

Journal: Journal of the anus, rectum and colon

Published: May 10, 2024

Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study.

Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study.

Journal: Intestinal research

Published: May 01, 2024

Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study.

Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study.

Journal: Intestinal research

Published: April 09, 2024

Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.

Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.

Journal: International journal of clinical oncology

Published: January 31, 2024

Impact of the COVID-19 pandemic on the time to emergency endoscopy and clinical outcomes in patients with upper gastrointestinal bleeding.

Impact of the COVID-19 pandemic on the time to emergency endoscopy and clinical outcomes in patients with upper gastrointestinal bleeding.

Journal: DEN open

Published: July 05, 2023

Updates in the Field of Submucosal Endoscopy.

Updates in the Field of Submucosal Endoscopy.

Journal: Life (Basel, Switzerland)

Published: November 19, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026